Articles tagged with 'Memory Disorders' | Cedars-Sinai Medical Center

The Associated Press (AP) recently interviewed neurologist Sarah Kremen, MD, who leads the Alzheimer’s Disease Clinical Trial Program at Cedars-Sinai, about why the recently approved Alzheimer’s medication lecanemab—shown to slow the …

The U.S. Food and Drug Administration (FDA) recently granted approval to lecanemab, the first Alzheimer’s disease treatment to win approval since the largely failed rollout of Aduhelm two years ago. Sold under the brand name Leqembi, the new drug …

Cedars-Sinai announced today a $10 million gift to establish the Bernard and Maxine Platzer Lynn Family Memory and Healthy Aging Program in the Department of Neurology. The program will broaden the scope of age-related care at Cedars-Sinai—with a …